Dongming Jiang

Dongming Jiang

Auto-generated profile, based on publicly available information

Dongming Jiang

Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2022 in Journal of Advanced Research
Verified
Journal Article
Open access
DJDongming Jiang
Dongming Jiang
ZNZheyun Niu
Zheyun Niu
XTXiaojie Tan
Xiaojie Tan
HHHaiwei He
Haiwei He
LRLongbing Ren
Longbing Ren
GCGuangwen Cao
Guangwen Cao
Female-specific cancers seriously affect physical and psychological health of women worldwide. We aimed to elucidate trends in the age-standardized mortality rates (ASMRs) of breast cancer, cervical cancer, uterine cancer, and ovarian cancer in female populations with different socioeconomic statuses in China and in countries with different Human Development Index (HDI). A longitudinal study was performed using the data of cancer death in China and other 39 countries. The mortality rates were standardized with the Segi’s world population. Trends in the mortalities were exhibited by estimated annual percentage change (EAPC). Pearson correlation was used to assess the association between EAPC and HDI. In mainland China, female breast cancer, cervical cancer, uterine cancer, and ovarian cancer accounted for 6.60 %, 4.21 %, 2.50 %, and 2.02 % of cancer death (n = 1,314,040) in women with 1,220,251,032 person-years, respectively. The ASMRs of cervical cancer (EAPC = 3.87 %, P < 0.001) and ovarian cancer (EAPC = 1.81 %, P < 0.001) increased, that of female breast cancer unchanged, whereas that of uterine cancer was extremely higher and rapidly decreased (EAPC = − 7.65 %, P < 0.001), during 2004–2019. The ASMRs of female breast and ovarian cancers were higher in urban and developed regions than in rural and undeveloped regions, in contrast to cervical and uterine cancers. The ASMRs of female breast and ovarian cancers were lower in China than in other countries, in contrast to uterine cancer. The ASMR of cervical cancer decreased, that of uterine cancer increased, in other countries during 2004–2017. EAPCs for the ASMRs of breast and ovarian cancers were inversely correlated to HDI. The ASMRs of cervical and ovarian cancers increased, in contrast to uterine cancer, in China during socioeconomic transition. Trends in the ASMRs of breast and ovarian cancers were inversely associated with HDI. These data help control female-specific cancers.

23 March 2021 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
QLQi Li
Qi Li
LZLiang Zheng
Liang Zheng
YGYijun Gu
Yijun Gu
DJDongming Jiang
Dongming Jiang
GWGuanghua Wang
Guanghua Wang
XAXu Anyang
Xu Anyang

1 June 2021 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
QLQi Li
Qi Li
LZLiang Zheng
Liang Zheng
YGYijun Gu
Yijun Gu
DJDongming Jiang
Dongming Jiang
GWGuanghua Wang
Guanghua Wang
XAXu Anyang
Xu Anyang

20 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MRMurugananthkumar Raju
Murugananthkumar Raju
PMPhilip Irwin Motakatla
Philip Irwin Motakatla
HKHamed Khedmatgozar
Hamed Khedmatgozar
RNRaaghav Nandana
Raaghav Nandana
DJDongming Jiang
Dongming Jiang
MTManisha Tripathi
Manisha Tripathi
Background: Homeobox transcription factors regulate developmental programs, cellular plasticity, and tumor progression, yet the role of H2.0-like homeobox (HLX) in prostate cancer (PCa) remains poorly defined. We investigated the clinical significance of HLX and its relationship to the pro-metastatic transcription factor TBX2. Methods: Transcriptomic and clinical datasets from TCGA, MET500, and SU2C/PCF cohorts were analyzed to assess HLX expression, clinicopathologic associations, and its relationship with TBX2. Functional studies in human PCa cell lines included TBX2 gain- and loss-of-function, HLX knockdown, chromatin immunoprecipitation (ChIP), and expression analyses. Shared HLX- and TBX2-associated pathways were evaluated by Reactome enrichment analysis, and Hallmark Gene Set Enrichment Analysis compared castration-resistant prostate cancer (CRPC) bone metastases with high versus low HLX expression (GSE77930; n = 5/group). In vivo relevance was assessed in an orthotopic TBX2 dominant-negative PCa xenograft model. Results: Human PCa datasets showed that HLX expression was elevated in PCa versus normal prostate tissue and associated with higher Gleason grade, lymph node involvement, aggressive molecular subtypes, and shorter disease-free survival. HLX expression also positively correlated with TBX2 across human PCa cohorts. HLX- and TBX2-associated transcriptional programs converged on extracellular matrix organization, cell adhesion, NOTCH, and VEGF-MAPK signaling pathways. Furthermore, HLX-high CRPC bone metastases were enriched for epithelial–mesenchymal transition, NOTCH, TGF-β, inflammatory, angiogenic, hypoxic, and KRAS signaling pathways. Mechanistic studies showed that HLX knockdown suppressed extracellular matrix-associated genes and key NOTCH pathway components. ChIP demonstrated direct TBX2 binding to the HLX promoter, and genetic modulation of TBX2 expression established HLX as a downstream target of TBX2. Consistent with these findings, reduced HLX expression in orthotopic TBX2 dominant-negative xenografts was associated with loss of metastatic progression. Conclusions: HLX is a candidate biomarker of aggressive PCa and a direct transcriptional target of TBX2. These findings identify a previously unrecognized TBX2–HLX regulatory axis associated with metastatic transcriptional programs and aggressive disease in advanced PCa.